Drugmaker Biogen Inc beat analysts' estimates for quarterly profit and lift...
) beat analysts’ estimates for quarterly profit and lifted its 2019 earnings forecast on Tuesday, driven by higher sales of its top-selling multiple sclerosis therapy Tecfidera.
Shares of the company were marginally up in volatile early trade, having given up their early gains as investors worried over the long-term prospects of Biogen’s most closely watched growth driver Spinraza. The company said overseas sales of Spinraza came under pressure from pricing adjustment in France and as patients moved to a lower-priced maintenance dose from an induction dose in some mature markets.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Stocks making the biggest moves premarket: Coca-Cola, Travelers, Biogen, Hasbro, Apple & moreThese are the stocks posting the largest moves before the bell.
Leer más »
Whirlpool earnings beat estimates as higher prices offset tariff impactWhirlpool Corp on Monday reported better-than-expected quarterly earnings and li...
Leer más »
Stocks making the biggest moves premarket: Coca-Cola, Travelers, Biogen, Hasbro, Apple & moreThese are the stocks posting the largest moves before the bell.
Leer más »
Love Island's Amy Hart 'will need months of therapy after villa ordeal'Amy Hart has committed to more that a year of therapy to help her get through the aftermath of a traumatic experience on Love Island
Leer más »
Video on Caring for Someone With Multiple MyelomaWhen a loved one is in and out of rounds of treatment, it changes the ways they need help, and they may not always ask. Some ways you can be strong caregiver:
Leer más »
ICYMI: Nordstrom Anniversary Sale Picks, Slingback Flats & Clear HandbagsICYMI — Nordstrom anniversary sale picks, slingback flats & clear handbags:
Leer más »